Global Biopharmaceutical Market Size, Status and Forecast 2020-2026

SKU ID : QYR- 15851249

Publishing Date : 25-Jun-2020

No. of pages : 90

PRICE
3900
5850
7800

  • A biopharmaceutical, also known as a biologic (al) medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenic, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.
    North America has the highest market share for the estimated period owing to presence of sophisticated healthcare infrastructure, growing geriatric population base and increased healthcare expenditure in the region. Asia Pacific is expected to register the highest growth rate for the forecasted period mainly due to presence of unmet market opportunities in the region.

    Market Analysis and Insights: Global Biopharmaceutical Market
    The global Biopharmaceutical market size is projected to reach US$ 230710 million by 2026, from US$ 214570 million in 2020, at a CAGR of 7.0%% during 2021-2026.

    Global Biopharmaceutical Scope and Market Size
    Biopharmaceutical market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Biopharmaceutical market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study


    Roche
    Amgen
    AbbVie
    Sanofi-Aventis
    Johnson & Johnson
    Pfizer
    Novo Nordisk
    Eli Lilly
    Novartis
    Merck

    Market segment by Type, the product can be split into


    Monoclonal Antibodies
    Interferon
    Erythropoietin
    Insulin
    Other

    Market segment by Application, split into


    Tumor
    Diabetes
    Cardiovascular
    Hemophilia
    Other

    Market segment by Regions/Countries, this report covers


    North America
    Europe
    China
    Japan
    Southeast Asia
    India

    Frequently Asked Questions



    This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

    • By product type
    • By End User/Applications
    • By Technology
    • By Region

    The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
    market Reports market Reports